SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-002283
Filing Date
2022-01-06
Accepted
2022-01-06 20:56:08
Documents
1
Period of Report
2022-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5697
  Complete submission text file 0001209191-22-002283.txt   7694
Mailing Address 17 RUE DE SERENE PARIS I0 75008
Business Address 17 RUE DE SERENE PARIS I0 75008 33 1 53 05 41 13
Sofinnova Partners SAS (Reporting) CIK: 0001574139 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41201 | Film No.: 22516297

Mailing Address 7-11 BOULEVARD HAUSSMANN PARIS I0 75009
Business Address 7-11 BOULEVARD HAUSSMANN PARIS I0 75009 33(0)1 76 23 41 00
Sofinnova Capital IX (Reporting) CIK: 0001849915 (see all company filings)

Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41201 | Film No.: 22516296

Mailing Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116 8445311834
CinCor Pharma, Inc. (Issuer) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences